TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tevogen Bio Holdings ( (TVGN) ) has shared an announcement.
On July 3, 2025, Tevogen Bio Holdings Inc. entered into a Sales Agreement with A.G.P./Alliance Global Partners to potentially issue and sell up to $50,000,000 of its common stock through an at-the-market equity offering. This agreement allows the company flexibility in issuing shares and includes provisions for sales parameters, agent commissions, and termination rights, which could impact the company’s financial strategy and market presence.
The most recent analyst rating on (TVGN) stock is a Buy with a $10.00 price target. To see the full list of analyst forecasts on Tevogen Bio Holdings stock, see the TVGN Stock Forecast page.
Spark’s Take on TVGN Stock
According to Spark, TipRanks’ AI Analyst, TVGN is a Underperform.
Tevogen Bio Holdings faces substantial financial risks due to consistent losses and high leverage, which are typical in its industry. Technical analysis indicates a bearish trend, and valuation metrics show speculative investment characteristics. However, the recent corporate event involving a strategic agreement provides a positive outlook for operational advancements, slightly balancing the financial and technical concerns.
To see Spark’s full report on TVGN stock, click here.
More about Tevogen Bio Holdings
Average Trading Volume: 1,008,131
Technical Sentiment Signal: Sell
Current Market Cap: $225M
For detailed information about TVGN stock, go to TipRanks’ Stock Analysis page.